Okada T, Imai Y, Osawa T
Division of Chemical Toxicology and Immunochemistry, Faculty of Pharmaceutical Sciences, University of Tokyo, Japan.
Immunol Lett. 1990 Jun;24(3):185-90. doi: 10.1016/0165-2478(90)90046-s.
We examined the in vivo localization of Con A sup-cultured murine splenocytes separated with Dolichos biflorus agglutin (DBA) to elucidate the mechanism underlying the high antitumor efficacy of cells which are not agglutinable with DBA (DBA- cells). First, 51Cr-labeled DBA-separated cells were injected intravenously (i.v.) into mice and then the tissues were collected for gamma counting. DBA- cells showed significant localization in the spleen, compared with DBA+ cells. This was further confirmed by injecting Thy1.2-positive DBA- cells into Thy1.1 congenic mice. Furthermore, after [3H]TdR-labeled DBA-separated cells had been injected i.v., the spleens of the recipients were fixed, sectioned and processed for autoradiography to determine in which region of the spleen the labeled cells had accumulated. We found that DBA- cells were especially concentrated in the white pulp of the spleen, where lymphocytes are localized before being recirculated. These results suggest that DBA- cells exert strong antitumor activity in vivo partly due to their localization in the spleen and partly to the high incidence of active recirculation.
我们检测了用双花扁豆凝集素(DBA)分离的刀豆球蛋白A(Con A)超培养小鼠脾细胞的体内定位,以阐明不能被DBA凝集的细胞(DBA-细胞)具有高抗肿瘤疗效的潜在机制。首先,将51Cr标记的经DBA分离的细胞静脉注射到小鼠体内,然后收集组织进行γ计数。与DBA+细胞相比,DBA-细胞在脾脏中显示出显著的定位。将Thy1.2阳性的DBA-细胞注射到Thy1.1同基因小鼠中进一步证实了这一点。此外,在静脉注射[3H]TdR标记的经DBA分离的细胞后,对受体的脾脏进行固定、切片并进行放射自显影处理,以确定标记细胞在脾脏的哪个区域积聚。我们发现DBA-细胞特别集中在脾脏的白髓中,淋巴细胞在再循环之前就定位在那里。这些结果表明,DBA-细胞在体内发挥强大的抗肿瘤活性,部分原因是它们在脾脏中的定位,部分原因是活跃再循环的高发生率。